# Codex Review: medical_monitoring_my008_p2_two_snapshot_revalidation_20260802

Date: 2026-08-02 (CST)
Review mode: Codex direct, offline, read-only. Hermes task context was
initialized, but no delegated agent, provider, conference, service, browser,
or runner was dispatched.

## Verdict

**Pass for source-byte and deterministic diff revalidation only.** This review
does not create a `MedicalRiskMappingReviewOutcome`, approve onboarding, or
open B6/C13/C14.

## Boundary Check

- No delegated agent was used. The two workbooks were read only; writes are
  limited to the declared task context, active-slice evidence, review, and
  metrics files.
- No product source, SQLite/runtime, Source Registry, B6/C13/C14, provider,
  service, browser, 8911/5174, `App.jsx`, `styles.css`, or medical-writing file
  was changed.

## Codex Verification

- Current workbook hashes exactly match the historical P2 evidence anchors.
- Current parser produced 33 sheets/32 domains for each workbook and zero
  parser warnings; classifier returned `raw_full_snapshot_candidate` for both.
- Current normalization and `monitoring_batch_diff.v3` reproduced 25,156 new,
  1,258 changed, 7,401 persisting, 40 removed, 5,295 field changes, zero
  schema diffs, and zero blocked removals.
- `tests/test_monitoring_source_classifier.py` plus
  `tests/test_monitoring_batch_diff.py`: 30 passed, 2 existing library warnings.
- Parser/classifier/diff `py_compile`: passed.
- No browser, runtime, service, provider, or clinical acceptance was run; those
  are intentionally outside this gate.

## Delegated-Agent Output Review

Not applicable. The direct replay is traceable to the current files, the P2
record, and the versioned parser/classifier/diff implementation. The review
does not infer clinical meaning from row counts or diff counts.

## Residual Risk

The `full_snapshot_proven` flag was supplied from the existing frozen-source
assertion in the P2 record; this revalidation did not independently sign or
mutate the Source Registry. Protocol/field/visit mapping, reviewer outcomes,
risk migration, independent AI, three-project scientific acceptance, browser
UAT, and commercial release remain open.
